Investment analyst, Jim Kumpel of Friedman Billings Ramsey, says NME approvals are “on pace with a miserable 2007". Through the first two months of this year, the FDA has approved only one NME, which is the same rate as 2007.
Pharmalot
Wednesday, 12 March 2008
Analyst: Fewer NME approvals expected in 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment